Executives from two ag biotech companies that raised major funding in 2017 shared some of their success secrets to a group of North Carolina peers this week.
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
Foundation Medicine, a Cambridge, Massachusetts firm selling genomic cancer tests, opened a precision health laboratory in Morrisville last year that it is growing into a major facility.
Bioscience briefs with names making news
The successes expected from CRISPR-Cas systems “Will come first in agriculture,” said North Carolina University food scientist, Rodolphe Barrangou, Ph.D., at the 8th annual NU-Tech Roundtable.
Triangle Business Journal’s latest annual roundup of the 50 fastest-growing private companies in the Triangle region includes two bioscience companies and seven others that provide valuable life science support functions.
Executives from two ag biotech companies that raised north of $20 million in capital recently will offer their insights on “Secrets for Raising Capital to Build Startups” at the AgBiotech Professional Forum September 27 at the North Carolina Biotechnology Center.
Dignify Therapeutics, a drug development company focused on restoring bladder and bowel control for the elderly and for people with spinal injury, multiple sclerosis or diabetes, continues to draw federal grants from the National Institutes of Health for its research and development.
The North Carolina Biotechnology Center is hosting the second annual VaccinatioNCelebration flu shot clinic all day Tuesday, Oct. 17, 2017, to highlight North Carolinians’ production of the newest generation of flu vaccine.
BioreclamationIVT, a New York company that sells biospecimens and related services, primarily for drug safety testing, has purchased Durham’s Qualyst Transporter Solutions for an undisclosed sum.
Raleigh-based Innovate Biopharmaceuticals has received U.S. Food and Drug Administration orphan drug designation for an experimental oral drug to treat pediatric ulcerative colitis.
Jack Bailey, president of U.S. Pharmaceuticals for GlaxoSmithKline, says an internship he served at the Biotech Center was a major influence in his successful career as a global pharmaceutical company leader.
Sixteen life science companies throughout North Carolina have received just over $1 million in grants from a state program to support their development of new technologies and products.